Emerging drug - Resistance and guidelines for treatment of malaria

Journal of the College of Physicians and Surgeons Pakistan

Volumn 14, Issue 5, 2004, Pages 319-324

  Khan, M Aslam ^a   Smego Jr , Raymond A ^a   Razi, Syed Tabish ^b   Beg, M Asim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b King Abdul Aziz Hospital   (Saudi Arabia)

Author keywords

Artemisinin based combination therapy; Drug resistance; Guidelines; Malaria; Pakistan

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; BENFLUMETOL; BICARBONATE; CHLOROQUINE; CLINDAMYCIN; DIURETIC AGENT; DOXYCYCLINE; FANSIDAR; FANSIMEF; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HALOFANTRINE; MEFLOQUINE; OXYGEN; PARASITE ANTIGEN; PRIMAQUINE; QUINIDINE; QUINIDINE GLUCONATE; QUININE; QUININE SULFATE; TETRACYCLINE;

ABORTION; ACUTE KIDNEY TUBULE NECROSIS; ANEMIA; ANTIGEN DETECTION; ARTICLE; BACTERIAL INFECTION; BITTER TASTE; BLEEDING DISORDER; BLOOD EXAMINATION; BRAIN MALARIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONVULSION; DIAGNOSTIC TEST; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DYSPHORIA; FOLLOW UP; GLOMERULONEPHRITIS; HEARING IMPAIRMENT; HEART DISEASE; HEMOLYTIC ANEMIA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LABORATORY TEST; LOW BIRTH WEIGHT; LUNG EDEMA; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; NAUSEA; NEPHROTIC SYNDROME; NONHUMAN; PAKISTAN; PATIENT CARE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREMATURE LABOR; PREVALENCE; PUBLIC HEALTH SERVICE; QT PROLONGATION; RESPIRATORY DISTRESS; SHOCK; STANDARDIZATION; TASTE DISORDER; TINNITUS; TREATMENT PLANNING;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; PAKISTAN; PHENANTHRENES; PLASMODIUM FALCIPARUM; QUINIDINE; QUININE; SESQUITERPENES; TIME FACTORS;

EID: 3142678061     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Strickland GT. Malaria. In: Strickland GT, (edi). Hunter's tropical medicine and emerging infectious disease. 8th ed. Philadelphia: WB Saunders; 2000.
2. Price RN, Nosten F. Drug-resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resistance Update 2001;4: 187-96.
3. Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK II, et al. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. Am J Trop Med Hyg 1999;61:968-72.
4. White NJ. Pressure increases for cheaper malaria drugs. In: Bio Med Net Conference Reporter from 10th International Congress on infectious diseases.2002 March 14. (website BioMedNet).
5. White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
6. Tish KN, Pillans PI. Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report. NZ Med J 1997;110:255-6.
7. Rowland M, Durrani N, Hewitt S, Sondrop E. Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: survey by the general health services using a simplified in vivo test. Trop Med Int Health 1997;2:1049-56.
8. Bojang KA, Schneider G, Forck S, Obaro SK, Jaffar S, Pinder M, et al. A trial of fansidar and chloroquine or fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 1998;92:73-6.
9. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, et al. A randomized controlled trial of artemether/benflumetol, a new antimalarial and primethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg 1998;58:638-44.
10. Fivelman QL, Walden JC, Smith PJ, Folb PI, Barnes KI. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1999;93:429-32.
11. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial. Lancet 2000;355:352-7.
12. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with a 3-day artesunate-mefloquine combination. J Infect Dis 1994;170:971-7.
13. Nosten F, Brasseur P. Combination therapy for malaria: the way forward? Drugs 2002;62:1315-29.
14. Nosten F, Ashley E. The detection and treatment of Plasmodium falciparum malaria: time for change. J Postgrad Med 2004;50:35-9.
15. Olliaro PL, Taylor WR. Developing artemisinin-based drug combinations for the treatment of drug-resistant falciparum malaria: a review. J Postgrad Med 2004;50:40-4.
16. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363:9-17.
17. Smego RA Jr, Beg A. Newer diagnostic modalities in malaria (editorial). J Pak Med Assoc 2000;50;398-99.
18. Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, et al. Diagnosis of malaria by detection of Plasmodium malaria HRP-2 antigen with a rapid dipstick antigen capture assay. Lancet 1994;343: 564-8.
19. Moleneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in pediatric cerebral malaria: a study of 131 comatose Malawian children. Quart J Med 1989;71:441-59.
20. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-1404.
21. Trang TT, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TT, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 1992;15:874-80.
22. White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983;309:61-6.
23. White NJ, Miller KD, Marsh K, Berry CD, Turner RC, Williamson DH, et al. Hypoglycemia in African children with severe malaria. Lancet 1987;1:708-11.
24. Hien TT, Arnold K, Vinh H, Cuong BM, Phu NH, Chau TT, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992;86:582-3.
25. Nosten F, van Vugt M, White NJ. Intrarectal artemisinin derivatives. Med Trop (Mars) 1998;58(suppl 3):63-4.
26. Udomsangpetch R, Pipitaporn B, Krishna S, Angus B, Pukrittayakamee S, Bates I, et al. Antimalarial drugs reduce cytoadherence and resetting of Plasmodium falciparum. J Infect Dis 1996;173:691-8.
27. Hien TT, Day NPJ, Phu NH, Mai NTG, Chau TTH, Loc PP, et al. A controlled trial of artemether and quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996;335:76-83.
28. Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug-resistant falciparum malaria. S Asian J Trop Med Pup Health 1992;23:762-7.
29. Gu HM, Warhurst DC, Peters W. Uptake of dihydroartemisinin by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1984;78:265-70.
30. Bakshi R, Hermeling-Ftitz I, Gathmann I, Alteri E. An integrated assessment of clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug. Trans R Soc Trop Med Hyg 2000;94:419-4.
31. Kshirsagar NA, Gogtay NJ, Moorthy NS, Garg MR, Dalvi SS, Chogle AR, et al. A randomized, double-blind, parallel- group, comparative safety and efficacy trial of oral co-aretemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India. Am J Trop Med Hyg 2000;62:402-8.
32. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, et al. Halofantrine vs. mefloquine in the treatment of multidrug- resistant falciparum malaria. Lancet 1993;341:1044-9.
33. van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335:69-75.
34. Pittler MH, Ernst E. Artemether for severe malaria: a meta-analysis of randomized clinical trials. Clin Infect Dis 1999;28:597-601.
35. Gupta S, Thapar MM, Mariga ST, Wernsdorfer WH, Bjorkman A. Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Exp Parasitol 2002;100:28-35.
36. Watt G, Loesuttivibool L, Shanks GD, Boudreau EF, Brown AE, Pavanand K, et al. Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand. Am J Trop Med Hyg 1992;47:108-11.
37. Pukrittayakamee S, Chantra A, Vanijanonta S, Clemens R, Looareesuwan S, White NJ. Therapeutic responses to quinine and clindamycin in multi-resistant falciparum infection. Antimicrob Agents Chemother 2000;44:2395-8.
38. Newton PN, Chierakul W, Ruangveerayuth R, Silamut K, Teerapong P, Krudsood S, et al. A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria. Trans R Soc Trop Med Hyg 2001;95:519-23.
39. Nosten F, ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341:1054-6.
40. Ezedinachi EN, Ekanem OJ, Chukwuani CM, Meremikwu MM, Ojar EA, Alaribe AA, et al. Efficacy and tolerability of a low- dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum. Am J Trop Med Hyg 1999;61:114-9.
41. World Health Organization. WHO Experts Committee Report on Malaria. 20th report. World Health Organization, Tech Report Ser 892,2000.